NCT07159386Recruiting
Advanced Fibrosis Detection for MASLD in Primary Care
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care
Source: ClinicalTrials.gov · Last updated 31 Mar 2026
Brief summary (registry, in English)
This proposal evaluates the implementation of a novel, non-interruptive, electronic health record alert for metabolic dysfunction-associated steatotic liver disease (MASLD) fibrosis risk assessment in primary care patients with MASLD using a stepped wedge, cluster randomized design. This work will generate generalizable data to dramatically enhance MASLD management in primary care.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 225 (estimated)
- First submitted
- 5 Aug 2025
- Start date
- 16 Mar 2026
- Primary completion date
- 30 Sept 2030
- Lead sponsor
- Medical University of South Carolina
- Diseases
- Obesity, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07159386
What you commit to
- Study type: Interventional
- Planned participants: 225
- From 16 Mar 2026 to the primary completion date, 30 Sept 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- All patients with cirrhosis, complications of cirrhosis (e.g. portal hypertension, hepatic encephalopathy), hepatocellular carcinoma, or previous liver transplant will be excluded.
Lab values
- pregnant women.
- Clinicians Clinicians will also be study participants, as we will be surveying them for feedback on the MASLD fibrosis risk assessment intervention. The MUSC primary care network at last count employed 122 clinicians across the 27 primary care practices.
Other
- None
Who the study is looking for
- Patients with a diagnosis code for MASLD
- Type 2 diabetes mellitus will
- 1\. All physicians, physician assistants, and nurse practitioners delivering primary care during the intervention phase of the study.
Criteria the registry did not label
- Patients
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of South Carolina Coordinator of this site? Confirm its status | Charleston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.